Cargando…
Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses
Autores principales: | Chen, Xuenian, Shi, Tongfei, Yang, Chao, Chen, Fangman, He, Xuan, Zhang, Kunbao, Hu, Hanze, Cai, Lulu, Leong, Kam W., Shao, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949828/ https://www.ncbi.nlm.nih.gov/pubmed/35338114 http://dx.doi.org/10.1038/s41392-022-00942-y |
Ejemplares similares
-
A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
por: Hu, Hanze, et al.
Publicado: (2021) -
Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection
por: Huo, Jian, et al.
Publicado: (2022) -
Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
por: Vijayan, Veena, et al.
Publicado: (2019) -
Thiol–Disulfide Exchange Coordinates the Release of Nitric Oxide and Dexamethasone for Synergistic Regulation of Intestinal Microenvironment in Colitis
por: Lu, Junna, et al.
Publicado: (2023) -
Protein nanovaccine confers robust immunity against Toxoplasma
por: El Bissati, Kamal, et al.
Publicado: (2017)